| Gene symbol | CLU | Synonyms | AAG4, APO-J, APOJ, CLI, CLU1, CLU2, KUB1, NA1/NA2, SGP-2, SGP2, SP-40, TRPM-2, TRPM2 | Type of gene | protein-coding |
| Chromosome | 8 | Map location | 8p21.1 | dbXrefs | |
| Description | clusterin | ||||
| GTO ID | GTC0018 |
| Trial ID | NCT00138658 |
| Disease | Lung Non-Small Cell Carcinoma |
| Altered gene | CLU |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | OGX-011|custirsen sodium|TV-1011 |
| Co-treatment | Gemcitabine|cisplatin|carboplatin |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | A Phase 1-2 Study of Weekly OGX-011 Plus a Gemcitabine/Platinum-Based Regimen in Patients With Stage IIIB or IV Non Small Cell Lung Cancer |
| Year | 2004 |
| Country | United States|Canada |
| Company sponsor | Achieve Life Sciences |
| Other ID(s) | OGX-011-05 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||